Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

782
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
782
Dementia01:30

Dementia

503
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
503

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-view Chest X-Ray Vision-Language Pre-training via Semantic-Aware Masked Language Modeling and High-order Alignment.

IEEE transactions on medical imaging·2026
Same author

Diffusion models for brain imaging computing: a survey of frameworks and applications.

Brain informatics·2026
Same author

Multimodal artificial intelligence in retinopathy of prematurity: A comprehensive narrative review.

Survey of ophthalmology·2026
Same author

Semi-URF: Progressive Uncertainty-Aware Region Filtering and Fusion for Semi-Supervised Medical Image Segmentation.

IEEE journal of biomedical and health informatics·2026
Same author

Structural-Functional Connectome Generation via Diffusion-Guided Graph Transformer for Alzheimer's Disease Analysis.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2026
Same author

A fundus image dataset for intelligent diabetic retinopathy system.

Scientific data·2026

Related Experiment Video

Updated: Jan 11, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

Alzheimer's Disease Risk Prediction and Pathogeny Extraction Using Fuzzy Graph Evolutionary Generative Adversarial

Xia-An Bi, Dayou Chen, Jie Wang

    IEEE Transactions on Neural Networks and Learning Systems
    |November 12, 2025
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel fuzzy graph evolutionary generative adversarial network (FGE-GAN) for predicting Alzheimer's disease (AD) risk. The FGE-GAN model enhances understanding of AD pathogenesis and improves early intervention strategies.

    More Related Videos

    Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
    08:43

    Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

    Published on: August 7, 2017

    8.4K
    Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
    09:38

    Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

    Published on: November 14, 2017

    15.6K

    Related Experiment Videos

    Last Updated: Jan 11, 2026

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.7K
    Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
    08:43

    Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

    Published on: August 7, 2017

    8.4K
    Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
    09:38

    Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

    Published on: November 14, 2017

    15.6K

    Area of Science:

    • Computational neuroscience
    • Artificial intelligence in medicine
    • Bioinformatics

    Background:

    • Accurate Alzheimer's disease (AD) risk prediction is crucial for clinical management.
    • The ambiguity in disease data impedes a comprehensive understanding of AD pathogenesis and limits predictive model efficacy.

    Purpose of the Study:

    • To develop an advanced model for Alzheimer's disease (AD) risk prediction by integrating fuzzy graph theory and deep learning.
    • To explore staged evolutionary patterns of AD and extract pathogenetic insights for early intervention.

    Main Methods:

    • Utilized fuzzy graphs to quantify interpathogeny associations via fuzzy memberships.
    • Developed a fuzzy entropy propagation model to describe AD deterioration as fuzzy entropy spread.
    • Introduced a fuzzy graph evolutionary generative adversarial network (FGE-GAN) with fuzzy graph convolution (FGC) layers for risk prediction and pathogeny extraction.

    Main Results:

    • The FGE-GAN model demonstrated superior performance in disease risk prediction compared to existing state-of-the-art methods.
    • Experiments on brain disease datasets validated the model's effectiveness.
    • Extracted multiomics pathogenetic factors offered valuable insights for early AD intervention.

    Conclusions:

    • The proposed FGE-GAN provides an interpretable and effective approach for Alzheimer's disease (AD) risk prediction.
    • The integration of fuzzy graph modeling and deep learning advances the understanding of AD pathogenesis.
    • The model's ability to extract pathogenetic insights supports the development of targeted early intervention strategies.